Citation Impact
Citing Papers
Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100
2012
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
2008 Standout
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer
2008
Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer
2012
Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
2008
Transcriptional Regulation by Nrf2
2017 Standout
A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra
2018
Improving the outcome of patients with castration-resistant prostate cancer through rational drug development
2006
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
The Roles of Leptin and Adiponectin
2005
Liver fibrosis
2005 Standout
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells†
2005
The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis
2005
Mechanisms of hepatic stellate cell activation
2017 Standout
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Mechanisms of liver fibrosis
2005
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARγ gene expression in primary rat hepatic stellate cells
2009
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Exendin‐4, a glucagon‐like protein‐1 (GLP‐1) receptor agonist, reverses hepatic steatosis in ob/ob mice†
2005
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Bisphenol A Exposure during Adulthood Alters Expression of Aromatase and 5α-Reductase Isozymes in Rat Prostate
2013
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
2012
Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells
2007
Biomedical applications of biodegradable polymers
2011 Standout
Focus on mammalian thioredoxin reductases — Important selenoproteins with versatile functions
2009
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-κB-dependent pathways
2009
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
2013 Standout
Biology of Incretins: GLP-1 and GIP
2007 Standout
Leptin Promotes the Myofibroblastic Phenotype in Hepatic Stellate Cells by Activating the Hedgehog Pathway
2010
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
2020 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
2019 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis
2006
Kupffer Cells Mediate Leptin-Induced Liver Fibrosis
2009
Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer
2015 Nature
Cellular and molecular mechanisms in liver fibrogenesis
2014
Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice
2017
Oxidative Stress in Cancer
2020 Standout
The thioredoxin antioxidant system
2013 Standout
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
The role of adipokines in liver fibrosis
2008
Changes in the Expression of Methionine Adenosyltransferase Genes and S-Adenosylmethionine Homeostasis During Hepatic Stellate Cell Activation
2009
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Hepatic fibrogenesis requires sympathetic neurotransmitters
2004
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences
2007
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
2018
A review of the carcinogenic potential of bisphenol A
2015
In Vitro and In Vivo Protection of Stellate Cells from Apoptosis by Leptin
2006
ROS and the DNA damage response in cancer
2018 Standout
Glucagon-Like Peptide-1 Receptor Is Present on Human Hepatocytes and Has A Direct Role in Decreasing Hepatic Steatosis in Vitro by Modulating Elements of the Insulin Signaling Pathway
2010
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
2014
Adipokines and liver fibrosis.
2006
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer.
1982 StandoutNobel
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Plk1 Inhibition Enhances the Efficacy of Androgen Signaling Blockade in Castration-Resistant Prostate Cancer
2014
Enzalutamide for the Treatment of Prostate Cancer: Results and Implications of the AFFIRM Trial
2014
Enzalutamide: A Novel Antiandrogen for Patients with Castrate-Resistant Prostate Cancer
2013
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer
2007
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet
2011
Experimental autoimmune orchitis after neonatal thymectomy in the mouse.
1981
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis.
1982 StandoutNobel
Enhanced angiogenesis of modified porcine small intestinal submucosa with hyaluronic acid‐poly(lactide‐co‐glycolide) nanoparticles: From fabrication to preclinical validation
2010
TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer
2013
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
PERMEABILITY OF SERTOLI CELL TIGHT JUNCTIONS TO LANTHANUM AFTER LIGATION OF DUCTUS DEFERENS AND DUCTULI EFFERENTES
1973
In silico structural prediction of human steroid 5α-reductase type II
2016
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Leptin Increases Tissue Inhibitor of Metalloproteinase I (TIMP-1) Gene Expression by a Specificity Protein 1/Signal Transducer and Activator of Transcription 3 Mechanism
2006
Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis
2005
Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells
2011
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers
2011
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Mark Titus being referenced
Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer
2005
SPERMAGGLUTININ FORMATION IN MALE RATS BY SUBCUTANEOUSLY INJECTED SYNGENEIC EPIDIDYMAL SPERMATOZOA AND BY VASOLIGATION OR VASECTOMY
1970
Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer
2016
Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate Cancer
2008
5α‐reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression
2010
5α‐androstane‐3α,17β‐diol supports human prostate cancer cell survival and proliferation through androgen receptor‐independent signaling pathways: Implication of androgen‐independent prostate cancer progression
2008
Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer
2013
Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor
2016
Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation
2004
Androgenic biomarker profiling in human matrices and cell culture samples using high throughput, electrospray tandem mass spectrometry
2014
Enzalutamide (ENZA) in combination with abiraterone acetate (AA) in bone metastatic castration resistant prostate cancer (mCRPC).
2014
Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone
2011
Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer
2005
MDV3100 effects on androgen receptor (AR) signaling and bone marrow testosterone concentration modulation: Apreliminary report.
2011
Leptin signal transduction in hepatic stellate cells involves activation of the mitogen activated protein kinase (MAPK) p44/p42, or ERK, as well as the signal transducer and activator of transcription 3 (Stat 3)
2003